These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 23155457)

  • 1. High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.
    Giovannetti E; van der Velde A; Funel N; Vasile E; Perrone V; Leon LG; De Lio N; Avan A; Caponi S; Pollina LE; Gallá V; Sudo H; Falcone A; Campani D; Boggi U; Peters GJ
    PLoS One; 2012; 7(11):e49145. PubMed ID: 23155457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.
    Hwang JH; Voortman J; Giovannetti E; Steinberg SM; Leon LG; Kim YT; Funel N; Park JK; Kim MA; Kang GH; Kim SW; Del Chiaro M; Peters GJ; Giaccone G
    PLoS One; 2010 May; 5(5):e10630. PubMed ID: 20498843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
    Jamieson NB; Morran DC; Morton JP; Ali A; Dickson EJ; Carter CR; Sansom OJ; Evans TR; McKay CJ; Oien KA
    Clin Cancer Res; 2012 Jan; 18(2):534-45. PubMed ID: 22114136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of selected microRNAs in pancreatic ductal adenocarcinoma: is there a relation to tumor morphology, progression and patient's outcome?
    Szabo A; Gurlich R; Liberko M; Soumarova R; Vernerova Z; Mandys V; Popov A
    Neoplasma; 2020 Sep; 67(5):1170-1181. PubMed ID: 32567937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.
    Permuth-Wey J; Chen YA; Fisher K; McCarthy S; Qu X; Lloyd MC; Kasprzak A; Fournier M; Williams VL; Ghia KM; Yoder SJ; Hall L; Georgeades C; Olaoye F; Husain K; Springett GM; Chen DT; Yeatman T; Centeno BA; Klapman J; Coppola D; Malafa M
    PLoS One; 2015; 10(1):e0116869. PubMed ID: 25607660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.
    Frampton AE; Krell J; Jamieson NB; Gall TM; Giovannetti E; Funel N; Mato Prado M; Krell D; Habib NA; Castellano L; Jiao LR; Stebbing J
    Eur J Cancer; 2015 Jul; 51(11):1389-404. PubMed ID: 26002251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
    Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
    Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
    Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H
    Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.
    Giovannetti E; Funel N; Peters GJ; Del Chiaro M; Erozenci LA; Vasile E; Leon LG; Pollina LE; Groen A; Falcone A; Danesi R; Campani D; Verheul HM; Boggi U
    Cancer Res; 2010 Jun; 70(11):4528-38. PubMed ID: 20460539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance.
    Ma MZ; Kong X; Weng MZ; Cheng K; Gong W; Quan ZW; Peng CH
    J Exp Clin Cancer Res; 2013 Sep; 32(1):71. PubMed ID: 24289824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C; Qi X
    J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
    Kent OA; Mullendore M; Wentzel EA; López-Romero P; Tan AC; Alvarez H; West K; Ochs MF; Hidalgo M; Arking DE; Maitra A; Mendell JT
    Cancer Biol Ther; 2009 Nov; 8(21):2013-24. PubMed ID: 20037478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.
    Wu Z; Zhou L; Ding G; Cao L
    Cancer Biomark; 2017; 18(1):35-39. PubMed ID: 27814273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma.
    Harada T; Uemura K; Sumiyoshi T; Shintakuya R; Okada K; Hara T; Takahashi S; Hiyama E
    Pancreatology; 2023 Dec; 23(8):996-1002. PubMed ID: 37945497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.